Encompass Health Corporation
EHC · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13 | $12 | $10 | $9 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $3 | $3 | $0 |
| Enterprise Value | $13 | $15 | $13 | $10 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 1.4% | 0.2% | 3.6% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 46.9% | 43% | 43.3% | 41.7% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 22.5% | 23.8% | 24% | 22.2% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 8.6% | 9.7% | 10.4% | 8.6% |
| EPS Diluted | 1.24 | 1.39 | 1.48 | 1.18 |
| % Growth | -10.8% | -6.1% | 25.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |